Targeted radiation shows lower neurological death rate in brain metastases from SCLC

Lung Cancer Research Foundation announces $3.75 million in research funding opportunities

The Lung Cancer Research Foundation announced funding opportunities to advance lung cancer research, including two new Team Science awards and an Early Career Investigator award.

July 18, 2025

Vol.51 No.28

Clinical Roundup

Steroids may make immunotherapy less effective for lung cancer patients, retrospective study finds

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer patients treated with immunotherapy, are the main reason certain immunotherapies may fail in treating the disease, according to research led by researchers at Keck Medicine of USC.

July 11, 2025

Vol.51 No.27

In Brief

City of Hope awarded $23.7M from ARPA-H for biomarker mapping

City of Hope has been awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health within the U.S. Department of Health and Human Services. The grant will help City of Hope create a biomap of tumor changes that cause immunotherapy resistance in advanced or metastatic non-small cell lung cancer.

June 20, 2025

Vol.51 No.24

Cancer Policy

AMA President Bobby Mukkamala, brain cancer survivor, says NIH research saved his life

In November 2024, Bobby Mukkamala was giving a routine talk to a group of physicians and medical students when his language suddenly became garbled. For a minute or two, he stopped making any sense.

FDA approves Ibtrozi oral treatment for advanced ROS1+ NSCLC

FDA has approved Ibtrozi (taletrectinib) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.

June 13, 2025

Vol.51 No.23

Clinical

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats

For more than a year before her stage 4 lung cancer was found, 35-year-old Alisa Secaida, a never-smoker and a physically active Southern Californian, had been experiencing a persistent cough and, increasingly, fatigue.

June 06, 2025

Vol.51 No.22

By Claire Marie Porter

Targeted radiation shows lower neurological death rate in brain metastases from SCLC

YOU MAY BE INTERESTED IN

Lung Cancer Research Foundation announces $3.75 million in research funding opportunities

Steroids may make immunotherapy less effective for lung cancer patients, retrospective study finds

City of Hope awarded $23.7M from ARPA-H for biomarker mapping

AMA President Bobby Mukkamala, brain cancer survivor, says NIH research saved his life

FDA approves Ibtrozi oral treatment for advanced ROS1+ NSCLC

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats

Renew today!

Subscriber content

Never miss an issue!

Login

Targeted radiation shows lower neurological death rate in brain metastases from SCLC

YOU MAY BE INTERESTED IN

Lung Cancer Research Foundation announces $3.75 million in research funding opportunities

Steroids may make immunotherapy less effective for lung cancer patients, retrospective study finds

City of Hope awarded $23.7M from ARPA-H for biomarker mapping

AMA President Bobby Mukkamala, brain cancer survivor, says NIH research saved his life

FDA approves Ibtrozi oral treatment for advanced ROS1+ NSCLC

Young women are now diagnosed with cancer at twice the rate of young menThe face of cancer is changing at a time when research is plagued by existential threats

Never miss an issue!

Login

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats